|  |
Jun 1, 2006
By:
Thomas T. Perls, MD, MPH, Brooke E. Salzman, MD, SAUL SCHAEFER, MD
|
 New statistics suggest that the gender gap in life expectancy between men and women is narrowing, but the disparity continues to be significant. Men lag behind women for reasons linked to biology, hormonal influences, and psychosocial and lifestyle factors. The consultants for this article offer strategies that can be implemented to better men's health.
Jun 1, 2006
By:
Thomas T. Perls, MD, MPH, Brooke E. Salzman, MD, SAUL SCHAEFER, MD
|
New statistics suggest that the gender gap in life expectancy between men and women is narrowing, but the disparity continues to be significant. Men lag behind women for reasons linked to biology, hormonal influences, and psychosocial and lifestyle factors. The consultants for this article offer strategies that can be implemented to better men's health. Twenty to thirty percent of men experience a rising PSA level after radical prostatectomy for prostate cancer, and much controversy exists about how best to manage these patients. In this symposium, an outstanding panel of experts discusses various approaches for different clinical scenarios involving this diverse population of men.
Dec 1, 2005
By:
JOSEPH A. SMITH, JR, MD, MICHAEL COOKSON, MD, M. Craig Hall, MD, Thomas E. Keane, MD, Raj S. Pruthi, MD
|
Twenty to thirty percent of men experience a rising PSA level after radical prostatectomy for prostate cancer, and much controversy exists about how best to manage these patients. In this symposium, an outstanding panel of experts discusses various approaches for different clinical scenarios involving this diverse population of men. The basic semen analysis may still be the cheapest and most effective means of evaluating the male for infertility. By separating the evidence from the myths about treating male infertility, we can help prevent patients from wasting time on worthless approaches.
Nov 1, 2005
By:
Sherman J. Silber, MD
|
The basic semen analysis may still be the cheapest and most effective means of evaluating the male for infertility. By separating the evidence from the myths about treating male infertility, we can help prevent patients from wasting time on worthless approaches. Abnormal inflammatory, autoimmune, and neuropathic responses may account for symptom severity and chronicity. If a primary course of antibiotic therapy fails, consider second-line therapies to alleviate symptoms based on these pathophysiologic mechanisms.
Aug 1, 2005
By:
Gregory S. Jack, MD, Scott I. Zeitlin, MD
|
Abnormal inflammatory, autoimmune, and neuropathic responses may account for symptom severity and chronicity. If a primary course of antibiotic therapy fails, consider second-line therapies to alleviate symptoms based on these pathophysiologic mechanisms. How you describe the risks and benefits of prostate cancer screening will influence your patient's decisions.
Jun 1, 2005
By:
Timothy Dudley, MD, John Nagle, MPA
|
How you describe the risks and benefits of prostate cancer screening will influence your patient's decisions. Jan 1, 2005
By:
GEORGE P. N. SAMRAJ, MD, LOUIS KURITZKY, MD, ALLEN D. SEFTEL, MD
|
The epidemiologic burden of premature ejaculation is substantial, and treatment can produce favorable results. If no remediable change has precipitated this common problem, physicians can reasonably consider pharmacotherapy, unless the patient prefers counseling. To what extent can testosterone replacement therapy restore the vigor of youth? Knowing when therapy is medically warranted requires clinical judgment to address the individual patient's needs.
Dec 1, 2004
By:
ANDRÉ T. GUAY, MD, S. MITCHELL HARMAN, MD, ABRAHAM MORGENTALER, MD
|
Testosterone, classically used to treat hypogonadism, is rapidly gaining popularity as an elixir for youth and virility. The perception that testosterone can counter the symptoms of aging, which seems to have taken hold in the public consciousness, is subject to controversy because the evidence for such claims has not been substantiated in the scientific literature. While it is readily accepted that testosterone levels naturally decline as men age, the inverse implication, that adding testosterone will reverse aging, has yet to be demonstrated. Aug 15, 2004
By:
Roger S. Kirby, MD
|
While the mainstay of medical treatment for BPH continues to be alpha-adrenergic blockers and 5alpha-reductase inhibitors, combination therapy provides expanded options and can result in a delay in the time to clinical progression.
|
| |
| 
